To the Editor We read the article titled “Radiation-Related Cancer Risk Associated With Surveillance Imaging for Metastasis From Choroidal Melanoma” by Wen et al1 with great interest. As research clinicians who have investigated the expanding use of fluorodeoxyglucose positron emission tomography (PET)/computed tomography (CT) in ophthalmic oncology, we agree that all radiographic tests should be used judiciously.2,3 Eye cancer specialists should not only exploit the benefits of radiographic imaging but also be aware of its relative risks. Thus, it is reasonable to remind us all that radiation carries a systemic, dose-related risk of cancer. However, these findings must be placed in perspective (as to not frighten patients) during the potential risks and benefits conversations that will be performed around the world.
Paul T. Finger, Aurélien Freton, Anna Pavlick. Radiation-Related Cancer Risk Associated With Radiographic Imaging. JAMA Ophthalmol. 2013;131(9):1248–1249. doi:10.1001/jamaophthalmol.2013.4025